Novartis Stuck With Sanctions In Bone Drug MDL
A federal judge on Monday levied roughly $55,000 in sanctions against Novartis Pharmaceuticals Corp. in a multidistrict litigation over allegedly concealed health risks associated with two bone cancer drugs, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article